companies / nexotx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
Nexo Therapeutics, Inc. was listed in New Enterprise Associates's portfolio, recorded 2026-09-27.
verified=2026-06-07 json
| total_raised | 60,000,00060.0M | ○ |
|---|---|---|
| founded | null | |
| hq | LITTLETON, CO | |
| industry | unknown | |
| stage | null |
Nexo Therapeutics is a drug-discovery company developing covalent medicines aimed at proteins long considered undruggable. It targets diseases driven by transcription factors, scaffolding proteins, and other targets traditional drugs cannot reach. Its covalent ligand discovery platform spans all nucleophilic amino acids and captures shallow, transient pockets that conventional approaches miss.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-03-27 | Funding round | 60,000,00060.0M | null | ○ |
| investor | src |
|---|---|
| New Enterprise Associates | ○ |
bootstrap, carto analytics, cloudflare, http/3, jquery 3.7.1, jquery migrate 3.4.1, mysql, php 8.4.21, underscore.js, understrap, wordpress 7.0
| fact | status | src |
|---|---|---|
| Funding round, $60.0M | attributed | ○ |
| Investor New Enterprise Associates | sourced | WEB |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-27provenance_investor_nea: unknown → sourced, WEB 2026-09-27 | provenance_investor_nea | unknown → sourced | WEB 2026-09-27 |
| 2026-09-25latest_round: seed, $60.0M, 2026-03-27 → Funding round, $60.0M, 2026-03-27, ○ 2026-06-07 | latest_round | seed, $60.0M, 2026-03-27 → Funding round, $60.0M, 2026-03-27 | ○ 2026-06-07 |
Records begin 2026-09-24. all_changes